Prediction of pathological stage in patients with clinical stage T1c prostate cancer: the new challenge.
about
Predictive Nuclear Chromatin Characteristics of Melanoma and Dysplastic NeviUsing nuclear morphometry to predict the need for treatment among men with low grade, low stage prostate cancer enrolled in a program of expectant management with curative intentThe role of magnetic resonance imaging (MRI) in prostate cancer imaging and staging at 1.5 and 3 Tesla: the Beth Israel Deaconess Medical Center (BIDMC) approachNuclear morphometry, nucleomics and prostate cancer progressionNomograms for the prediction of pathologic stage of clinically localized prostate cancer in Korean men.
P2860
Prediction of pathological stage in patients with clinical stage T1c prostate cancer: the new challenge.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Prediction of pathological sta ...... ate cancer: the new challenge.
@ast
Prediction of pathological sta ...... ate cancer: the new challenge.
@en
type
label
Prediction of pathological sta ...... ate cancer: the new challenge.
@ast
Prediction of pathological sta ...... ate cancer: the new challenge.
@en
prefLabel
Prediction of pathological sta ...... ate cancer: the new challenge.
@ast
Prediction of pathological sta ...... ate cancer: the new challenge.
@en
P2093
P1476
Prediction of pathological sta ...... ate cancer: the new challenge.
@en
P2093
Gerard J O'Dowd
Jonathan I Epstein
Leslie A Mangold
M Craig Miller
Robert W Veltri
P304
P356
10.1097/00005392-200207000-00023
P407
P577
2002-07-01T00:00:00Z